JHS Svendgaard Laboratories Limited has informed the Exchange regarding Re-Appointment of Mr. Nikhil Nanda as Managing Director of the company w.e.f. July 02, 2025.
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 0.2 pts more than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of JHS Svendgaard Laboratories, at its meeting on July 01, 2025, approved the re-appointment of Mr. Nikhil Nanda as Managing Director for a fresh term of five years effective July 02, 2025, subject to shareholder approval. Mr. Nanda is a first-generation entrepreneur with over 30 years of FMCG experience and founded the company in 1997, taking it public in 2006. Separately, Mr. Mukul Pathak ceased to be an Independent Director effective close of business on July 01, 2025, upon completion of his second term. The Nomination and Remuneration Committee was reconstituted following Mr. Pathak's exit.
Continuity at the top is maintained as the founder-promoter MD gets another five-year term, which is generally seen as a stability signal for shareholders. The departure of one independent director is a routine end-of-term event requiring committee reconstitution, with no negative governance implications indicated.